BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37364726)

  • 1. Synthesis and evaluation of Fmoc-amino esters and amides bearing a substrate like quaternary ammonium group as selective butyrylcholinesterase inhibitors.
    Godinez J; Lee CY; Schwans JP
    Bioorg Med Chem Lett; 2023 Aug; 92():129392. PubMed ID: 37364726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating Fmoc-amino acids as selective inhibitors of butyrylcholinesterase.
    Gonzalez J; Ramirez J; Schwans JP
    Amino Acids; 2016 Dec; 48(12):2755-2763. PubMed ID: 27522651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Compounds for Butyrylcholinesterase Inhibition.
    Li S; Li AJ; Travers J; Xu T; Sakamuru S; Klumpp-Thomas C; Huang R; Xia M
    SLAS Discov; 2021 Dec; 26(10):1355-1364. PubMed ID: 34269114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
    Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
    CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
    Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
    Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
    Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
    Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease.
    Saud A; Krishnaraju V; Taha A; Kalpana K; Malarkodi V; Durgaramani S; Vinoth Prabhu V; Saleh FA; Ezhilarasan S
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2522-2537. PubMed ID: 38567612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and Computational Analysis Identify Statins as Selective Inhibitors of Human Butyrylcholinesterase.
    Atay MS; Sari S; Bodur E
    Protein J; 2023 Apr; 42(2):104-111. PubMed ID: 36648628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, molecular docking and biological evaluation of N,N-disubstituted 2-aminothiazolines as a new class of butyrylcholinesterase and carboxylesterase inhibitors.
    Makhaeva GF; Boltneva NP; Lushchekina SV; Serebryakova OG; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Bachurin SO; Richardson RJ
    Bioorg Med Chem; 2016 Mar; 24(5):1050-62. PubMed ID: 26827140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses, cholinesterases inhibition, and molecular docking studies of pyrido[2,3-b]pyrazine derivatives.
    Hameed A; Zehra ST; Shah SJ; Khan KM; Alharthy RD; Furtmann N; Bajorath J; Tahir MN; Iqbal J
    Chem Biol Drug Des; 2015 Nov; 86(5):1115-20. PubMed ID: 25951978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of substituted acetamide derivatives as potential butyrylcholinestrase inhibitors.
    Yu D; Yang C; Liu Y; Lu T; Li L; Chen G; Liu Z; Li Y
    Sci Rep; 2023 Mar; 13(1):4877. PubMed ID: 36966194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
    Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
    Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
    Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
    Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico and in vitro studies confirm Ondansetron as a novel acetylcholinesterase and butyrylcholinesterase inhibitor.
    Gholami A; Minai-Tehrani D; Eriksson LA
    Sci Rep; 2023 Jan; 13(1):643. PubMed ID: 36635365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
    Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonols and 4-thioflavonols as potential acetylcholinesterase and butyrylcholinesterase inhibitors: Synthesis, structure-activity relationship and molecular docking studies.
    Mughal EU; Sadiq A; Ashraf J; Zafar MN; Sumrra SH; Tariq R; Mumtaz A; Javid A; Khan BA; Ali A; Javed CO
    Bioorg Chem; 2019 Oct; 91():103124. PubMed ID: 31319297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.